肿瘤热疗与肿瘤免疫在转化医学中的研究进展  

Progress of translational medicine in the tumor thermotherapy and tumor immunology

作　　者：何梦烨[1] 沈朋[1] 

机构地区：[1]浙江大学医学院附属第一医院肿瘤内科,浙江杭州310003

出　　处：《基础医学与临床》2012年第7期833-836,共4页Basic and Clinical Medicine

摘　　要：肿瘤热疗成为继手术、放疗、化疗和生物治疗后又一重要的肿瘤治疗手段。热休克蛋白及树突状细胞受热疗影响较大并与肿瘤免疫密切相关,逐渐受到基础研究及临床应用的重视。通过这些研究,热疗联合肿瘤免疫治疗逐渐成为转化医学中的研究重点,这一新的概念有希望改变现有的肿瘤治疗策略。Thermotherapy becomes another important cancer treatment apart from the surgery, radiotherapy, chem- otherapy and biological therapy. Heat shock proteins and dendritic cells which influenced by hyperthermia, corre- late with tumor immunology, and was studied from bench to bedside. According to these researches, the develop- ment of translational medicine in combination of thermotherapy and tumor immunology has been in concern, and may change the status in quo of the treatment of cancer.

关 键 词：肿瘤热疗 肿瘤免疫 热休克蛋白 树突状细胞 转化医学 

分 类 号：R730.5[医药卫生—肿瘤]